For in vitro diagnostic use. Others Elecsys Anti-HAV IgM IVD Elecsys® Anti-HAV IgM CPS_000436 11820591160 Anti-HAV IgM Elecsys cobas e 100 Elecsys Anti-HAV IgM 04015630938858 Reagents, kits 100 tests cobas e 411/601/602 true 11820591122 Anti-HAV IgM Elecsys cobas e 100 Elecsys Anti-HAV IgM 04015630917778 Reagents, kits 100 tests cobas e 411/601/602 true 07026773190 Anti-HAV IgM Elecsys E2G 300 Elecsys Anti-HAV IgM 04015630939855 Reagents, kits 300 tests cobas e 402/801 true 11820591501 Elecsys Anti-HAV IgM en 8 FF00000006EBBF0E FF0000000019AB0E 11820591160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti‑HAV IgM) in human serum and plasma (potassium EDTA, lithium or sodium heparin, sodium citrate). The assay is intended for use as an aid in the laboratory diagnosis of an acute or recently acquired hepatitis A virus infection. Assay results, in conjunction with other laboratory results and clinical information, may be used to provide presumptive evidence of infection with hepatitis A virus in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis A infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 11820591500 Elecsys Anti-HAV IgM en 18 FF00000007028F0E FF00000000373C0E 11820591122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to the hepatitis A virus in human serum and plasma. The assay is used as an aid to detect an acute or recently acquired hepatitis A virus infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07026773501 Elecsys Anti-HAV IgM en 4 FF000000053CCA0E FF0000000227420E 07026773190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti‑HAV IgM) in human serum and plasma (potassium EDTA, lithium or sodium heparin, sodium citrate). The assay is intended for use as an aid in the laboratory diagnosis of an acute or recently acquired hepatitis A virus infection. Assay results, in conjunction with other laboratory results and clinical information, may be used to provide presumptive evidence of infection with hepatitis A virus in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis A infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026773500 Elecsys Anti-HAV IgM en 2 FF000000020CBC0E FF0000000193570E 07026773190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to the hepatitis A virus in human serum and plasma. The assay is used as an aid to detect an acute or recently acquired hepatitis A virus infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07026773501 Elecsys Anti-HAV IgM en 5 FF00000005C8410E FF000000053CCA0E 07026773190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti‑HAV IgM) in human serum and plasma (potassium EDTA, lithium or sodium heparin, sodium citrate). The assay is intended for use as an aid in the laboratory diagnosis of an acute or recently acquired hepatitis A virus infection. Assay results, in conjunction with other laboratory results and clinical information, may be used to provide presumptive evidence of infection with hepatitis A virus in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis A infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026773500 Elecsys Anti-HAV IgM en 5 FF00000004A1DF0E FF0000000430B60E 07026773190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to the hepatitis A virus in human serum and plasma. The assay is used as an aid to detect an acute or recently acquired hepatitis A virus infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en